Close
Xylem
Novotech

Press Releases

Fourteen categories celebrate pharma innovation across supply chain and spotlight leaders driving excellence

CPHI announces the winners of the prestigious 2024 CPHI Pharma Awards. Once again, these recognise outstanding achievements and contributions made within the global pharma industry, across 14 wide-ranging categories, including two new ones: Future Leader and Woman of the...

Global Sustainability Collective and Women’s Mentoring Programme announced at CPHI Milan

Bio and Tides predicted to be the fastest growing modality for CDMOs over the next five years Ahead of CPHI Milan โ€“ the worldโ€™s largest pharma event, held at Fiera Milano โ€“ new insights from theย CPHI Annual Industry Survey*ย reveal...

CPHI Milan analysis Lombardy the best location for pharma manufacturing in Europe

Report predicts significant growth for Lombardyโ€™s pharma industry in 2025 as event directly contributes more than โ‚ฌ120m to region The global pharma industry arrives in Milan next month at CPHI Milan โ€“ the worldโ€™s biggest pharma event, held at Fiera...

Biotech Capital on the Rise and Outsourcing to Accelerate in 2025 – but Uneven Growth for CDMOs

European Biotech Recovery Gains Momentum as Chinese Biotech Declines, and IPO Activity Remains Weak New research launched at CPHI Milan โ€“ the worldโ€™s largest pharma event, held at Fiera Milano (October 08-10, 2024) โ€“ forecasts promising growth for biotech and...

CPHI Milan Report: CMOs and hybrid companies will hold 54% of biologics capacity in 2028

CMOs will account for four of the five biggest capacity holders in 2028, with 45% of all CMO capacity in Asia The worldโ€™s largest pharma event, CPHI Milan, is set to open at Fiera Milano from October 8- 10, 2024,...

Recipharm and Exela announce exclusive strategic alliance

Sterile manufacturing capability in the US with over 100 million readily-available units (including vials and Pre-Filled Syringes โ€“ PFS) Extensions to include ADCs and auto-injector assembly Site accredited by FDA (CDER and CBER) 1stย October 2024 - Recipharm, a leading...

CPHI Milan Survey faster CDMO growth in 2025 predicted and industry not in favour of BIOSECURE Act

CPHI Milan โ€“ the worldโ€™s largest pharma event, held at Fiera Milano โ€“ returns next month at a pivotal moment as contract services growth is predicted to accelerate in 2025. These predictions stem from new research findingsย from 280...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป